Cargando…

SOX17 increases the cisplatin sensitivity of an endometrial cancer cell line

BACKGROUND: Endometrial cancer (EC) is the most common form of malignant gynecological tumor. Treatment with cisplatin (CDDP) is the mainstay of EC chemotherapy. The apoptotic machinery is regarded as an important etiological factor in chemoresistance. Recent evidence has suggested that overexpressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yongli, Jiang, FeiZhou, Bao, Wei, Zhang, Huilin, He, XiaoYing, Wang, Huihui, Wan, Xiaoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826500/ https://www.ncbi.nlm.nih.gov/pubmed/27065754 http://dx.doi.org/10.1186/s12935-016-0304-7

Ejemplares similares

SOX17 is a tumor suppressor in endometrial cancer
por: Zhang, Yongli, et al.
Publicado: (2016)

SOX4 promotes the growth and metastasis of breast cancer
por: Zhang, Jing, et al.
Publicado: (2020)

SOX17 Inhibits Tumor Metastasis Via Wnt Signaling In Endometrial Cancer
por: Zhou, Weiqiang, et al.
Publicado: (2019)

Resistance to cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxicity
por: Freeburg, Elizabeth M, et al.
Publicado: (2009)

Sensitivity to cisplatin in primary cell lines derived from human glioma correlates with levels of EGR-1 expression
por: Calogero, Antonella, et al.
Publicado: (2011)

Progesterone receptor inhibits the proliferation and invasion of endometrial cancer cells by up regulating Krüppel-like factor 9
por: Yan, Xiaofang, et al.
Publicado: (2020)

Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment
por: Gao, Yanyun, et al.
Publicado: (2019)

Long non-coding RNA LINC00485 acts as a microRNA-195 sponge to regulate the chemotherapy sensitivity of lung adenocarcinoma cells to cisplatin by regulating CHEK1
por: Zuo, Wei, et al.
Publicado: (2019)

Midazolam increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via the miR-194-5p/HOOK3 axis
por: Sun, Tingting, et al.
Publicado: (2021)

Stigmasterol sensitizes endometrial cancer cells to chemotherapy by repressing Nrf2 signal pathway
por: Liao, Hong, et al.
Publicado: (2020)

Comparative evaluation of cisplatin and carboplatin sensitivity in endometrial adenocarcinoma cell lines.
por: Rantanen, V., et al.
Publicado: (1994)

Molecular mechanisms of heptaplatin effective against cisplatin-resistant cancer cell lines: less involvement of metallothionein
por: Choi, Cheol-Hee, et al.
Publicado: (2004)

ETS1 is associated with cisplatin resistance through IKKα/NF-κB pathway in cell line MDA-MB-231
por: Zhang, Yuzhu, et al.
Publicado: (2018)

Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness
por: Schmidtova, Silvia, et al.
Publicado: (2020)

MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin
por: Li, Weili, et al.
Publicado: (2016)

Apatinib suppresses tumor progression and enhances cisplatin sensitivity in esophageal cancer via the Akt/β-catenin pathway
por: Wei, Bin, et al.
Publicado: (2020)

The effects of MOTILIPERM on cisplatin induced testicular toxicity in Sprague–Dawley rats
por: Soni, Kiran Kumar, et al.
Publicado: (2015)

Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation
por: Gao, Jin, et al.
Publicado: (2020)

The MRTF-A/miR-155/SOX1 pathway mediates gastric cancer migration and invasion
por: Yin, Libin, et al.
Publicado: (2020)

MiR-155-5p suppresses SOX1 to promote proliferation of cholangiocarcinoma via RAF/MEK/ERK pathway
por: Wang, Da, et al.
Publicado: (2021)

Depleting TMED3 alleviates the development of endometrial carcinoma
por: Zhang, Jin, et al.
Publicado: (2022)

Promoter methylation status of the tumor suppressor gene SOX11 is associated with cell growth and invasion in nasopharyngeal carcinoma
por: Zhang, Song, et al.
Publicado: (2013)

Raltitrexed increases radiation sensitivity of esophageal squamous carcinoma cells
por: Ding, Wen-Xiu, et al.
Publicado: (2019)

Identification of long noncoding RNA RP11-89K21.1 and RP11-357H14.17 as prognostic signature of endometrial carcinoma via integrated bioinformatics analysis
por: Gao, Lingling, et al.
Publicado: (2020)

Analyzing the whole-transcriptome profiles of ncRNAs and predicting the competing endogenous RNA networks in cervical cancer cell lines with cisplatin resistance
por: Lv, Huimin, et al.
Publicado: (2021)

Establishment and characterization of a novel childhood acute lymphoblastic leukemia cell line, HXEX-ALL1, with chromosome 9p and 17p deletions
por: Zhu, Yiping, et al.
Publicado: (2019)

Overexpression of long non-coding RNA SOX2OT promotes esophageal squamous cell carcinoma growth
por: Wu, Yuanyuan, et al.
Publicado: (2018)

Integrated analysis of immune-related genes in endometrial carcinoma
por: Wang, Yiru, et al.
Publicado: (2020)

Prognostic value of an autophagy-related gene expression signature for endometrial cancer patients
por: Wang, Hui, et al.
Publicado: (2020)

Tumor-suppressor role of miR-139-5p in endometrial cancer
por: Liu, JinHui, et al.
Publicado: (2018)

miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway
por: Zheng, Tian-Liang, et al.
Publicado: (2019)

Hypermethylation of SOX2 Promoter in Endometrial Carcinogenesis
por: Wong, Oscar Gee-Wan, et al.
Publicado: (2010)

LINC00662 enhances cell progression and stemness in breast cancer by MiR-144-3p/SOX2 axis
por: An, Congjing, et al.
Publicado: (2022)

Potential new biomarkers for endometrial cancer
por: Townsend, Michelle H., et al.
Publicado: (2019)

SOX2OT knockdown derived changes in mitotic regulatory gene network of cancer cells
por: Saghaeian Jazi, Marie, et al.
Publicado: (2018)

SOX2 interferes with the function of CDX2 in bile acid-induced gastric intestinal metaplasia
por: Yuan, Ting, et al.
Publicado: (2019)

Ubiquitin ligase CHAF1B induces cisplatin resistance in lung adenocarcinoma by promoting NCOR2 degradation
por: Gong, Lian, et al.
Publicado: (2020)

Prostaglandin E2 (PGE2) promotes proliferation and invasion by enhancing SUMO-1 activity via EP4 receptor in endometrial cancer
por: Ke, Jieqi, et al.
Publicado: (2016)

BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma
por: Li, Yibing, et al.
Publicado: (2020)

MicroRNA expression in human endometrial adenocarcinoma
por: Jurcevic, Sanja, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2c8m0pb17ccv9mqav3n0qgf089